Skip to main content
Signal8

WASSON GREGORY D

SEC insider (Form 3/4/5 filer). CIK 0001188827. Director at OptimizeRx Corp (OPRX) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 9, 2026. Located in WALTHAM, MA.

Companies WASSON GREGORY D has filed insider reports for

  • OptimizeRx Corp (OPRX): Director
  • P3 Health Partners Inc. (PIII): Director
WASSON GREGORY D profile photo

WASSON GREGORY D

CIK: 0001188827

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

OptimizeRx Corp logo
OPRX

OptimizeRx Corp

Director
P3 Health Partners Inc. logo
PIII

P3 Health Partners Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • OptimizeRx Corp logo
    OPRX

    OptimizeRx Corp

    Jun 9, 2026
    Award
    Direct
    34.5K shares-
  • P3 Health Partners Inc. logo
    PIII

    P3 Health Partners Inc.

    Aug 6, 2025
    Award
    Direct
    2K shares-
  • P3 Health Partners Inc. logo
    PIII

    P3 Health Partners Inc.

    Aug 6, 2025
    Award
    Direct
    2K shares-
  • OptimizeRx Corp logo
    OPRX

    OptimizeRx Corp

    Jun 11, 2025
    Award
    Direct
    9.9K shares-

1-4 of 4